文献速递神经免疫

多基因风险评分与基于人群出生年队列中多发性硬化终生风险的关联

Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort.
PubMed 文献 · Neurology · 2024-09-13

在荷兰Project Y出生年队列中,计算285例多发性硬化患者与267名对照者的多基因风险评分(PRS),按对照者PRS分布十分位分析终生风险。女性PRS最低30%者终生风险1:2,739,最高10%者1:92;男性分别为1:7,900与1:293。PRS与发病年龄及继发进展时间无显著关联。

要点

  • 女性PRS最低30%者多发性硬化终生风险为1:2,739,最高10%者为1:92。
  • 男性PRS最低30%者终生风险为1:7,900,最高10%者为1:293。
  • PRS与发病年龄及继发进展时间在男女中均无显著关联。

核心结论

  • 多发性硬化的终生风险受遗传因素强烈影响。
  • 作者认为高PRS可增强诊断确定性,而PRS分布最低尾端应视为警示信号,可能避免将模拟多发性硬化的疾病误诊。

研究设计与样本

  • 基于人群的出生年队列研究(Project Y研究),追踪1966年出生的荷兰多发性硬化患者,对照来自Project Y队列(1965-1967年出生)及阿姆斯特丹痴呆队列(1963-1969年出生)的非多发性硬化参与者。
  • 对285例多发性硬化患者(平均年龄53.0±0.9岁,72.3%女性)和267名对照者(平均年龄51.8±3.2岁,58.1%女性)计算基于最大规模多发性硬化遗传研究变异及权重的多基因风险评分,并按对照者PRS分布十分位分组。

主要发现

  • 女性PRS最低30%组多发性硬化终生风险为1:2,739,最高10%组为1:92。
  • 男性PRS最低30%组终生风险为1:7,900,最高10%组为1:293。
  • PRS与发病年龄及继发进展时间在男女中均无显著关联。

临床怎么用

  • 作者认为高PRS可增强疑似多发性硬化者的诊断确定性。
  • 作者认为PRS分布最低尾端应视为警示信号,可能避免将模拟多发性硬化的疾病误诊。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: More than 200 genetic variants have been associated with multiple sclerosis (MS) susceptibility. However, it is unclear to what extent genetic factors influence lifetime risk of MS. Using a population-based birth-year cohort, we investigate the effect of genetics on lifetime risk of MS. METHODS: In the Project Y study, we tracked down almost all persons with MS (pwMS) from birth year 1966 in the Netherlands. As control participants, we included non-MS participants from the Project Y cohort (born 1965-1967 in the Netherlands) and non-MS participants from the Amsterdam Dementia Cohort born between 1963 and 1969. Genetic variants associated with MS were determined in pwMS and control participants using genotyping or imputation methods. Polygenic risk scores (PRSs) based on variants and weights from the largest genetic study in MS were calculated for each participant and assigned into deciles based on the PRS distribution in the control participants. We examined the lifetime risk for each decile and the association between PRS and MS disease variables, including age at onset and time to secondary progression. RESULTS: MS-PRS was calculated for 285 pwMS (mean age 53.0 ± 0.9 years, 72.3% female) and 267 control participants (mean age 51.8 ± 3.2 years, 58.1% female). Based on the lifetime risk estimation, we observed that 1:2,739 of the women with the lowest 30% genetic risk developed MS, whereas 1:92 of the women with the top 10% highest risk developed MS. For men, only 1:7,900 developed MS in the lowest 30% genetic risk group, compared with 1:293 men with the top 10% genetic risk. The PRS was not significantly associated with age at onset and time to secondary progression in both sexes. DISCUSSION: Our results show that the lifetime risk of MS is strongly influenced by genetic factors. Our findings have the potential to support diagnostic certainty in individuals with suspected MS: a high PRS could strengthen a diagnosis, but especially a PRS from the lowest tail of the PRS distribution should be considered a red flag and could prevent misdiagnosing conditions that mimic MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Loonstra FC, Álvarez Sirvent D, Tesi N, et al. Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort. Neurology. 2024. PMID: 39270152. doi:10.1212/WNL.0000000000209663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。